Shandong Sito Bio-technology Co Ltd Working Capital to Net Assets Ratio
Shandong Sito Bio-technology Co Ltd working capital to net assets ratio. Shandong Sito Bio-technology Co Ltd (300583) has a Working Capital to Net Assets ratio of 14.7% as of June 2026. Working capital of CN¥263.67 Million (current assets of CN¥1.27 Billion minus current liabilities of CN¥1.00 Billion) is measured against net assets of CN¥1.80 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shandong Sito Bio-technology Co Ltd (2012–2025)
Working capital to net assets ratio of Shandong Sito Bio-technology Co Ltd from 2012 to 2025. This chart shows how Shandong Sito Bio-technology Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 14.7%, reflecting working capital of CN¥263.67 Million against net assets of CN¥1.80 Billion CNY. Explore how much of Shandong Sito Bio-technology Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Shandong Sito Bio-technology Co Ltd Working Capital to Net Assets Ratio by Year (2012–2025)
Shandong Sito Bio-technology Co Ltd working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Sito Bio-technology Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Shandong Sito Bio-technology Co Ltd's balance sheet.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 15.5% | CN¥278.66 Million | CN¥1.80 Billion | CN¥1.28 Billion | CN¥1.01 Billion | ▲ +1.6 pp |
| 2024 | 13.9% | CN¥261.24 Million | CN¥1.88 Billion | CN¥1.28 Billion | CN¥1.02 Billion | ▼ -6.0 pp |
| 2023 | 19.9% | CN¥411.03 Million | CN¥2.07 Billion | CN¥1.40 Billion | CN¥986.76 Million | ▲ +16.8 pp |
| 2022 | 3.1% | CN¥55.48 Million | CN¥1.77 Billion | CN¥1.14 Billion | CN¥1.08 Billion | ▲ +1.7 pp |
| 2021 | 1.5% | CN¥25.31 Million | CN¥1.73 Billion | CN¥1.08 Billion | CN¥1.05 Billion | ▼ -10.4 pp |
| 2020 | 11.9% | CN¥201.38 Million | CN¥1.69 Billion | CN¥1.14 Billion | CN¥940.73 Million | ▼ -18.0 pp |
| 2019 | 29.9% | CN¥563.65 Million | CN¥1.89 Billion | CN¥1.51 Billion | CN¥943.05 Million | ▼ -22.0 pp |
| 2018 | 51.9% | CN¥966.24 Million | CN¥1.86 Billion | CN¥1.67 Billion | CN¥704.13 Million | ▼ -8.4 pp |
| 2017 | 60.3% | CN¥1.03 Billion | CN¥1.71 Billion | CN¥1.34 Billion | CN¥306.56 Million | ▲ +26.4 pp |
| 2016 | 33.9% | CN¥204.22 Million | CN¥603.01 Million | CN¥367.88 Million | CN¥163.66 Million | ▼ -3.7 pp |
| 2015 | 37.5% | CN¥190.10 Million | CN¥506.66 Million | CN¥370.07 Million | CN¥179.97 Million | ▲ +21.1 pp |
| 2014 | 16.5% | CN¥47.87 Million | CN¥290.80 Million | CN¥152.63 Million | CN¥104.75 Million | ▼ -53.2 pp |
| 2013 | 69.7% | CN¥68.87 Million | CN¥98.83 Million | CN¥135.51 Million | CN¥66.63 Million | ▲ +57.0 pp |
| 2012 | 12.7% | CN¥4.12 Million | CN¥32.47 Million | CN¥31.63 Million | CN¥27.51 Million | — |